News for Immune Therapeutics, Inc. (IMUN)

News for Immune Therapeutics, Inc.
Date Headline
Jul 19, 2018 08:30 AM Research on Lodonal for HIV related GI complications featured in Plus Magazine
Jun 05, 2018 12:14 PM (CORRECTION) Immune Therapeutics Acquires 10% Stake in Cytocom; Obtains Exclusive Rights to Lodonal™ for Pets in United States
Jun 05, 2018 08:00 AM Immune Therapeutics Acquires 10% Stake in Cytocom; Obtains Exclusive Rights to Lodonal™ for Pets in United States
Apr 26, 2018 08:30 AM Immune Therapeutics, Inc. Files New Drug Application for Lodonol™ in Kenya to Target HIV Epidemic
Nov 30, 2017 09:58 AM Immune Therapeutics, Inc. Shareholder Update Letter
Sep 06, 2017 08:05 AM Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million